Swine flu is caused by the H1N1 influenza virus. It spreads through coughing, sneezing or touching contaminated surfaces. Symptoms include fever, sore throat, cough, body aches, and fatigue. High risk groups include young children, pregnant women, the elderly, and those with pre-existing medical conditions. Tamiflu is the recommended treatment. Prevention involves covering coughs and sneezes, frequent hand washing, avoiding touching the face, and distancing from infected individuals.

2. CONTENT
What is Swine flu?
Symptoms of Swine flu?
Mode of Transmission ?
Period of Communicability?
Incubation Period?
Prevention of Swine flu
TAKE HOME MESSAGE

3. WHAT IS SWINE FLU?
It is a respiratory disease caused by H1 N1
Type A Influenza Virus.
It is like ordinary flu.
The Swine flu was initially seen in humans in
Mexico in 2009, where the strand of the
particular virus was a marriage of 3 types of
strands.

4. WHAT IS SWINE FLU?

5. WHAT IS SWINE FLU?

6. WHAT IS SWINE FLU?
 The major reason of its world wide spread is
the lack of immunity against the virus in a
large population.
WHO declares swine flu as pandemic on 11
June 2009.

7. SYMPTOMS OF SWINE FLU?

8. SYMPTOMS OF SWINE FLU?
 Fever
 Sore Throat
 Cough
 Headache
 Body ache
 Lethargy
 Diarrhoea and Vomiting

9. Mode of Transmission?

10. Mode of Transmission?
 Cough and Sneezing by Infected Indl
 Virus deposited on any Surface
 Healthy indl touches the contaminated surface
 Healthy Indl touches his Eyes, Nose or Mouth
 Healthy Indl becomes infected

11. Period of Communicability?
1 Day 7 Days

12. Incubation Period?
2 Days
(1-4 Days)

13. High Risk Group
 Children with mild illness
but with predisposing risk factors.
 Pregnant women;
 Persons aged 65 years or older;
 Patients with lung diseases,
heart disease, liver disease, kidney disease, blood
disorders, diabetes, neurological disorders, cancer and
HIV/AIDS;
 Patients on long term cortisone therapy.

14. Warning Signals in Adults ?
 Breathlessness,
 chest pain,
 drowsiness,
 fall in blood pressure,
 sputum mixed with blood,
 bluish discolouration of nails;
 Confusion

15. Warning Signals in Children
(Red Flag Signs) ?
 Somnolence,
 high and persistent fever,
 inability to feed well,
 convulsions,
 shortness of breath,
 difficulty in breathing,
 Inconsolable cry, etc.

16. Prevention and control
 In order to prevent and contain outbreak of
Influenza virus the following guidelines for
screening, testing and isolation are to be followed:
 At first all individuals seeking consultations for flu
like symptoms should be screened at healthcare
facilities both Government and private or examined
by a doctor and these will be categorized as under:

17. Category A
 Patients with mild fever plus cough / sore throat
with or without bodyache, headache, diarrhoea and
vomiting will be categorized as Category-A.
 They do not require Oseltamivir and should be
treated for the symptoms mentioned above. The
patients should be monitored for their progress and
reassessed at 24 to 48 hours by the doctor.
 No testing of the patient for Influenza is required.
 Patients should confine themselves at home and
avoid mixing up with public and high risk members
in the family.

18. Category B
 (i) In addition to all the signs and symptoms
mentioned under Category-A, if the patient has high
grade fever and severe sore throat, may require
home isolation and Oseltamivir;
 (ii) In addition to all the signs and symptoms
mentioned under Category-A, individuals having
one or more of the following high risk conditions
shall be treated with Oseltamivir:

19. Category B
 Children with mild illness but with predisposing risk
factors.
 Pregnant women;
 Persons aged 65 years or older;
 Patients with lung diseases, heart disease, liver
disease, kidney disease, blood disorders, diabetes,
neurological disorders, cancer and HIV/AIDS;
 Patients on long term cortisone therapy

20. Category B
 No tests for Influenza is required for Category-B (i)
and (ii).
 All patients of Category-B (i) and (ii) should confine
themselves at home and avoid mixing with public
and high risk members in the family.
 Broad Spectrum antibiotics as per the Guideline for
Community-acquired pneumonia (CAP) may be
prescribed.

21. Category C
 In addition to the above signs and symptoms of
Category-A and B, if the patient has one or more of
the following:
 Breathlessness, chest pain, drowsiness, fall in blood
pressure, sputum mixed with blood, bluish
discolouration of nails;

22. Category C
 Children with influenza like illness who had a severe
disease as manifested by the red flag signs
(Somnolence, high and persistent fever, inability to
feed well, convulsions, shortness of breath,
difficulty in breathing, etc).
 Worsening of underlying chronic conditions.
 All these patients mentioned above in Category-C
require testing, immediate hospitalization and
treatment.

23. Prevention

24. रोकथाम के उपाय
क्या करैं
१. ख ांसते य छ ांकते समय अपने
मांह व न क को टिश्यू य रूम ल से
कवर करैं |
२. अपनी आांख, न क य मांह को
छू ने से पहले ह थों को अच्छ तरह
स बन से धोयें |
३. बीम र व्यक्तत से दूरी बन ये
रखें |
४. कोई भी तकलीफ होने पर
डॉतिर की सल ह अवश्य लें |
५. खूब प नी पीयें, पोषक भोजन
ख यें और भरपूर नीांद लें |
क्या नह ीं करैं
१.ह थ ममल ने, गले ममलने और
चम्बन लेने से बचें |
२. भीड़ व ले स्थ नों पर ज ने से
बचें |
३. फ्लू रोगी के अधधक ननकि न
ज यें |
४. जह ाँ तक हो सके अपनी आाँख,
न क य मांह को न छयें |
५. अपने ह थों पर ख ांसे य छ कें
नहीां
६. ड तिर की सल ह के बबन
कोई दव ई न लें |

25. Vaccine
 While declaring the Pandemic to be over in August
2010, WHO conveyed that Pandemic Influenza A
(HINI) virus that caused Pandemic [2009-2010]
would circulate as Seasonal Influenza virus and
would continue to do so for years to come.
 WHO recommended vaccine only for High Risk Group
 Ministry of Health and Family Welfare recommends
the trivalent inactivated influenza vaccine.

26. Vaccine
 The ICMR has recommended on the following
Seasonal Influenza vaccine composition, for the
period 2017-2018. The recommended Trivalent
vaccine should have:
 an A/Michigan/45/2015 (H1N1)pdm09-like virus
 an A/Hong Kong/4801/2014 (H3N2) – like virus
 a B/Brisbane/60/2008-like virus

27. Vaccine
 The available vaccine takes about 2-3 weeks for
development of immunity. Hence for the health care
workers working in an environment with likelihood of
exposure to Influenza virus, vaccine should be
administered at least one month prior to the
commencement of the season, till such time use of
chemoprophylaxis may be considered.

28. Vaccine
 The available vaccine takes about 2-3 weeks for
development of immunity. Hence for the health care
workers working in an environment with likelihood of
exposure to Influenza virus, vaccine should be
administered at least one month prior to the
commencement of the season, till such time use of
chemoprophylaxis may be considered.

29. Limitations of the Influenza
Vaccination
 Influenza vaccination is most effective when
circulating viruses are well-matched with vaccine
viruses.
 Even with appropriate matching, efficacy of vaccine
may be about 70% to 80%.
 In case the locally circulating virus is different from
vaccine virus recommended by WHO, it may be
partially effective or not be effective at all.
 Hence, vaccine should not give a false sense of
security.

30. High Risk Groups for whom
vaccine is recommended by WHO
 Health Care workers, working in hospital / institutional
settings (doctors, nurses, paramedics) with likelihood
of exposure to Influenza virus
 Young children
 Pregnant women;
 Persons aged 65 years or older;
 Patients with Comorbidity
 Patients with compromised immunity

31. USE OF MASKS
 There are two types of masks which are recommended
for various categories of personnel depending upon the
work environment;
1. Triple layer surgical mask 2. N 95 Respirator
 Change the mask after six hours or as soon as they
become wet.
 Disposable masks are never to be reused and should be
disposed off.
 Never touch the potentially infected outer surface of
the mask while removing it.

32. USE OF MASKS
 There is no scientific evidence to show health benefit of
using masks for members of public. In fact erroneous
use of masks or continuous use of a disposable mask
for longer than 6 hours or repeated use of same mask
may actually increase risk of infection further.
 In the hospital setting used masks should be disposed
off in the identified infectious waste disposal
bag/container.
 In community settings, it may be disposed off either by
burning or deep burial.

33. Triple layer surgical mask
 Suspect/ probable/confirmed cases of influenza.
 The care provider in home care settings
 Close family contacts of such cases undergoing home
care should also use Triple layer surgical mask.
 All medical personnel (Doctor, nursing and paramedical
staff) would use Disposable Triple layer surgical mask
while interacting with patients in screening area.
 All patients, Medical and nursing staff in the isolation
wards.

34. Triple layer surgical mask
 Personnel involved in handling dead bodies of
suspect/confirmed cases (Mortuary)
 Ambulance Staff including driver.
 Doctors /Private practitioners with other health
workers in screening centres / general practice
 Health workers involved in community surveillance
 Security personnel working in an infected/ potentially
infected area for example Influenza ward in a hospital,
screening centre etc.

35. N 95 Respirator
 Staff involved in any aerosol generating procedures
like suction, intubation, nebulization, etc. they must
use N95 Respirator
 Medical personnel need to collect clinical samples from
patients.
 Medical personnel in ICU
 Medical personnel in laboratory

36. Tamiflu (Oseltamivir)
 Oseltamivir is the recommended drug for treatment.
Dose for treatment is as follows -
 By Weight:
 o For weight <15kg 30 mg BD for 5 days
 o 15-23kg 45 mg BD for 5 days
 o 24-<40kg 60 mg BD for 5 days
 o >40kg 75 mg BD for 5 days

37. Tamiflu (Oseltamivir)
 For infants:
 o < 3 months 12 mg BD for 5 days
 o 3-5 months 20 mg BD for 5 days
 o 6-11 months 25 mg BD for 5 days
 It is also available as syrup (12mg per ml)

38. Q 1. SWINE FLU IS CAUSED BY ?
A. BACTERIA
B. VIRUS
C. (FUNGUS
D. CONTAMINATED WATER

39. Q 1. SWINE FLU IS CAUSED BY ?
B. VIRUS

40. Q 2. SWINE FLU SPREAD
INCREASES IN ?
A. Winters
B. Summers
C. Rain
D. Spring

41. Q 2. SWINE FLU SPREAD
INCREASES IN ?
Winters & Rainy
season

42. Q3. DRUG USED IN SWINE FLU
TREATMENT?
A. AMIKACIN
B. TAMIFLU (OSELTAMIVIR)
C. CETRIZINE
D. GLICLAZIDE

43. Q3. DRUG USED IN SWINE FLU
TREATMENT ?
B. TAMIFLU

44. Q4. SYMPTOMS OF SWINE FLU ARE ?
A.Fever
B.Sore throat
C.Cough
D. Body ache
E. All of the above

45. Q4. SYMPTOMS OF SWINE FLU ARE ?
E. All of the above

46. Q5. What are the preventive
measures of Swine flu ?
A. Cover your cough and sneeze.
B. Wash your hands at regular interval.
C. Avoid touching your eye, nose and mouth
unnecessarily.
D. Keep safe distance from an infected
individual.
E. All of the above.

47. Q5. What are the preventive
measures of Swine flu ?
E. All of the above

48. TAKE HOME MESSAGE